The Human Glycoproteomics Initiative (HGI) was established in 2017 by Prof Nicki Packer (Chair) and Dr. Morten Thaysen-Andersen (Deputy Chair) (both Macquarie University, Sydney, Australia). The HGI evolved from the Human Glyco/Proteomics Initiative (HGPI) (2004-2016) headed by Prof. N Taniguchi and Dr. H. Narimatsu.
The HGI aims to increase the understanding of the functional significance of the extensive post translational protein modifications by glycans. This can only be achieved when the proteomics community has the technology and informatics tools to more easily enable the determination of site-, cell- and organ- specific glycoform structural heterogeneity in complex biological systems. The HGI is comprised of a number of researchers and collaborators throughout the world who are dedicated to fostering and accelerating research progress in disease glycomics by pursuing collaborative and interdisciplinary research. This initiative will connect the other HPP activities in HUPO more tightly and will permit the exchange of information of mutual interest. The data and information will be shared with members, non-participating researchers and will be made available for public, academic research and teaching purposes. In order to avoid diluting efforts by other on-going related activities, this initiative focuses on disease glycoproteomics.